These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides. Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model. Miyake T; Aoki M; Morishita R Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361 [TBL] [Abstract][Full Text] [Related]
11. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330 [TBL] [Abstract][Full Text] [Related]
12. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Azuma H; Tomita N; Kaneda Y; Koike H; Ogihara T; Katsuoka Y; Morishita R Gene Ther; 2003 Mar; 10(5):415-25. PubMed ID: 12601396 [TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Matsuda N; Hattori Y; Jesmin S; Gando S Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632 [TBL] [Abstract][Full Text] [Related]
15. Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs. Kupatt C; Wichels R; Deiss M; Molnar A; Lebherz C; Raake P; von Degenfeld G; Hahnel D; Boekstegers P Gene Ther; 2002 Apr; 9(8):518-26. PubMed ID: 11948377 [TBL] [Abstract][Full Text] [Related]
16. Intracellular distribution of NFkappaB decoy and its inhibitory effect on TNFalpha production by LPS stimulated RAW 264.7 cells. Higuchi Y; Kawakami S; Nishikawa M; Yamashita F; Hashida M J Control Release; 2005 Oct; 107(2):373-82. PubMed ID: 16125268 [TBL] [Abstract][Full Text] [Related]
18. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts. Suzuki J; Morishita R; Amano J; Kaneda Y; Isobe M Gene Ther; 2000 Nov; 7(21):1847-52. PubMed ID: 11110417 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545 [TBL] [Abstract][Full Text] [Related]
20. [The effects of nuclear factor-kappaB decoy oligonucleotides on dextran sulphate sodium-induced colitis: experiment with mice]. Wu LG; Gan HT; Ou YQ; Peng L; Zhang M Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1394-9. PubMed ID: 16796922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]